Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacological therapy for acute stroke: the future

B N Panayiotou1, M D Fotherby

  • 1Department of Clinical Pharmacology, City General Hospital, Stoke on Trent.

The British Journal of Clinical Practice
|November 1, 1995
PubMed
Summary

Drug therapy for stroke shows limited potential due to complex pathophysiology and patient factors. Prevention strategies and organized stroke units offer greater public health benefits.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Twenty-four hour blood pressure following stroke.

Journal of internal medicine·2002
Same author

Twenty-four hour systolic blood pressure predicts long-term mortality following acute stroke.

Journal of hypertension·2001
Same author

Responses to the prolonged head-up tilt followed by sublingual nitrate provocation in asymptomatic older adults.

Age and ageing·2000
Same author

Mononuclear cell adhesion to collagen ex vivo is related to pulse pressure in elderly subjects.

Atherosclerosis·2000
Same author

Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons.

Journal of hypertension·2000
Same author

Antihypertensive therapy in the prevention of stroke: what, when and for whom?

Drugs·1999

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Public Health

Background:

  • Stroke is a leading cause of death, disability, and healthcare costs.
  • Significant research efforts have targeted drug development to mitigate brain damage post-stroke.
  • Current drug development faces challenges in significantly impacting stroke outcomes.

Purpose of the Study:

  • To evaluate the potential impact of drug therapy in acute stroke.
  • To compare the efficacy of drug interventions with public health strategies.
  • To identify more effective approaches for reducing the burden of stroke.

Main Methods:

  • Review of existing data on stroke pathophysiology and drug trial outcomes.
  • Analysis of the complexity of the ischemic cascade and intervention timing.
  • Assessment of the impact of pre-existing conditions in elderly stroke patients.
  • Evaluation of the potential benefits of primary and secondary stroke prevention.
  • Consideration of the role of organized stroke unit services.

Main Results:

  • The complex pathophysiology of stroke limits the effectiveness of single or dual-target drug interventions.
  • Early intervention is crucial, but often difficult to achieve in clinical practice.
  • Pre-existing conditions in elderly patients reduce their recovery potential.
  • Primary and secondary prevention strategies, alongside organized stroke services, show greater potential for public health impact.
  • Despite enthusiasm, drug therapy for acute stroke is predicted to have disappointing overall results.

Conclusions:

  • Drug therapy for acute stroke is unlikely to yield substantial breakthroughs due to inherent complexities.
  • A multi-faceted approach combining prevention, timely intervention, and organized care is more promising for reducing stroke's public health burden.
  • Future efforts should prioritize public health strategies over solely relying on drug development for acute stroke management.

Related Experiment Videos